Visit COVID-19 resources

[Skip to Content]

Elyeal

Statement in response to NICE announcing their positive final guidance for Eylea® for the treatment of macular oedema secondary to CRVO

Dec 30
2014

Statement from The Royal College of Ophthalmologists in response to NICE announcing their positive final guidance for Eylea® for the treatment of macular oedema secondary to CRVO February 2014

  • 30 December 2014